VRAX

Virax Biolabs Group Limited - Ordinary Shares (VRAX)

About Virax Biolabs Group Limited - Ordinary Shares (VRAX)

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Details

Daily high
$0.16
Daily low
$0.16
Price at open
$0.16
52 Week High
$1.14
52 Week Low
$0.10
Market cap
3.2M
Dividend yield
0.00%
Volume
74,259
Avg. volume
4.3M
P/E ratio
-.13

Virax Biolabs Group Limited - Ordinary Shares News

Details

Daily high
$0.16
Daily low
$0.16
Price at open
$0.16
52 Week High
$1.14
52 Week Low
$0.10
Market cap
3.2M
Dividend yield
0.00%
Volume
74,259
Avg. volume
4.3M
P/E ratio
-.13